Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0001209191-23-018004

Options or other derivatives

  • General Counsel acquired 71,795 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wahl Bryan · General Counsel

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-03-08 Grant or award : show line 1 in the form Stock Option (right to buy) +42,802 42,802 D
2023-03-08 Grant or award : show line 2 in the form Restricted Stock Units +28,993 28,993 D
Loading xslF345X03/doc4.xml…